Article 11 Jul 2024 When APA Claims Accrue Under Corner Post: Implications For The Life Sciences Industry United States Healthcare
Article 03 Jul 2024 Chevron Overturned: What Does It Mean For Life Sciences Companies? United States Healthcare
Article 22 Jul 2022 OIG Advisory Opinion On Continuing Education Provides Insight On Risk Areas United States Healthcare
Video 02 May 2022 Arnold & Porter Life Sciences: Pharmaceutical Pricing & Contracting (Video) United States Healthcare
Article 26 Jan 2022 HHS-OIG Rule Expands Opportunities For Advisory Opinions United States Healthcare
Article 25 Nov 2021 Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know United States Healthcare
Article 25 Nov 2020 Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now United States Healthcare
Article 01 Oct 2020 FDA Issues Proposed Rule To Amend Intended Use Regulations United States Healthcare
Article 27 Jan 2020 A New Private Right Of Action Is Created For Refusals To Provide Drugs And Biologics To Certain Product Developers United States Healthcare